nodes	percent_of_prediction	percent_of_DWPC	metapath
Caffeine—ATM—urinary bladder cancer	0.554	1	CbGaD
Caffeine—ABCB1—Mitomycin—urinary bladder cancer	0.0307	0.168	CbGbCtD
Caffeine—CYP1B1—Doxorubicin—urinary bladder cancer	0.0251	0.137	CbGbCtD
Caffeine—CYP3A4—Thiotepa—urinary bladder cancer	0.0139	0.0761	CbGbCtD
Caffeine—CYP2E1—Etoposide—urinary bladder cancer	0.0125	0.0681	CbGbCtD
Caffeine—CYP2C8—Fluorouracil—urinary bladder cancer	0.0112	0.061	CbGbCtD
Caffeine—CYP3A5—Etoposide—urinary bladder cancer	0.0097	0.0529	CbGbCtD
Caffeine—CYP2C8—Etoposide—urinary bladder cancer	0.00932	0.0509	CbGbCtD
Caffeine—ABCB1—Gemcitabine—urinary bladder cancer	0.00884	0.0483	CbGbCtD
Caffeine—CYP1A2—Fluorouracil—urinary bladder cancer	0.00865	0.0472	CbGbCtD
Caffeine—CYP2C9—Fluorouracil—urinary bladder cancer	0.00779	0.0425	CbGbCtD
Caffeine—CYP1A2—Etoposide—urinary bladder cancer	0.00722	0.0394	CbGbCtD
Caffeine—CYP2C9—Cisplatin—urinary bladder cancer	0.00662	0.0361	CbGbCtD
Caffeine—ABCB1—Cisplatin—urinary bladder cancer	0.00642	0.0351	CbGbCtD
Caffeine—ABCB1—Etoposide—urinary bladder cancer	0.00631	0.0345	CbGbCtD
Caffeine—ABCB1—Doxorubicin—urinary bladder cancer	0.0043	0.0235	CbGbCtD
Caffeine—ABCB1—Methotrexate—urinary bladder cancer	0.00417	0.0228	CbGbCtD
Caffeine—CYP2D6—Doxorubicin—urinary bladder cancer	0.00406	0.0221	CbGbCtD
Caffeine—CYP3A4—Etoposide—urinary bladder cancer	0.00378	0.0206	CbGbCtD
Caffeine—CYP3A4—Doxorubicin—urinary bladder cancer	0.00258	0.0141	CbGbCtD
Caffeine—ATM—prostate gland—urinary bladder cancer	0.00233	0.0309	CbGeAlD
Caffeine—PRKDC—prostate gland—urinary bladder cancer	0.0022	0.0292	CbGeAlD
Caffeine—PIK3CD—prostate gland—urinary bladder cancer	0.00206	0.0274	CbGeAlD
Caffeine—Necrotising colitis—Epirubicin—urinary bladder cancer	0.00197	0.0463	CcSEcCtD
Caffeine—PRKDC—seminal vesicle—urinary bladder cancer	0.00186	0.0247	CbGeAlD
Caffeine—Necrotising colitis—Doxorubicin—urinary bladder cancer	0.00183	0.0429	CcSEcCtD
Caffeine—PIK3CB—prostate gland—urinary bladder cancer	0.0018	0.0239	CbGeAlD
Caffeine—PIK3CA—prostate gland—urinary bladder cancer	0.00178	0.0236	CbGeAlD
Caffeine—RYR1—prostate gland—urinary bladder cancer	0.00178	0.0236	CbGeAlD
Caffeine—ATM—epithelium—urinary bladder cancer	0.00171	0.0227	CbGeAlD
Caffeine—ATM—renal system—urinary bladder cancer	0.00158	0.021	CbGeAlD
Caffeine—PRKDC—smooth muscle tissue—urinary bladder cancer	0.00156	0.0207	CbGeAlD
Caffeine—PIK3CB—seminal vesicle—urinary bladder cancer	0.00152	0.0202	CbGeAlD
Caffeine—PIK3CD—epithelium—urinary bladder cancer	0.00152	0.0201	CbGeAlD
Caffeine—PIK3CA—seminal vesicle—urinary bladder cancer	0.00151	0.02	CbGeAlD
Caffeine—PRKDC—urethra—urinary bladder cancer	0.00147	0.0195	CbGeAlD
Caffeine—PIK3CD—smooth muscle tissue—urinary bladder cancer	0.00146	0.0194	CbGeAlD
Caffeine—PIK3CD—renal system—urinary bladder cancer	0.00141	0.0187	CbGeAlD
Caffeine—PIK3CB—epithelium—urinary bladder cancer	0.00132	0.0175	CbGeAlD
Caffeine—ADORA2B—prostate gland—urinary bladder cancer	0.00131	0.0174	CbGeAlD
Caffeine—PIK3CA—epithelium—urinary bladder cancer	0.00131	0.0174	CbGeAlD
Caffeine—PIK3CB—smooth muscle tissue—urinary bladder cancer	0.00127	0.0169	CbGeAlD
Caffeine—ATM—female reproductive system—urinary bladder cancer	0.00127	0.0169	CbGeAlD
Caffeine—RYR1—smooth muscle tissue—urinary bladder cancer	0.00126	0.0167	CbGeAlD
Caffeine—PIK3CA—smooth muscle tissue—urinary bladder cancer	0.00126	0.0167	CbGeAlD
Caffeine—PIK3CB—renal system—urinary bladder cancer	0.00123	0.0163	CbGeAlD
Caffeine—PIK3CA—renal system—urinary bladder cancer	0.00121	0.0161	CbGeAlD
Caffeine—PIK3CB—urethra—urinary bladder cancer	0.0012	0.016	CbGeAlD
Caffeine—PIK3CA—urethra—urinary bladder cancer	0.00119	0.0158	CbGeAlD
Caffeine—CYP1A2—urine—urinary bladder cancer	0.00119	0.0158	CbGeAlD
Caffeine—ATM—vagina—urinary bladder cancer	0.00115	0.0152	CbGeAlD
Caffeine—CYP2C9—urine—urinary bladder cancer	0.00113	0.015	CbGeAlD
Caffeine—Irritability—Valrubicin—urinary bladder cancer	0.00113	0.0265	CcSEcCtD
Caffeine—PIK3CD—female reproductive system—urinary bladder cancer	0.00113	0.0149	CbGeAlD
Caffeine—PRKDC—vagina—urinary bladder cancer	0.00109	0.0144	CbGeAlD
Caffeine—CYP2E1—urine—urinary bladder cancer	0.00107	0.0142	CbGeAlD
Caffeine—Cerebral haemorrhage—Thiotepa—urinary bladder cancer	0.00102	0.024	CcSEcCtD
Caffeine—Pulmonary oedema—Mitomycin—urinary bladder cancer	0.001	0.0235	CcSEcCtD
Caffeine—PIK3CB—female reproductive system—urinary bladder cancer	0.000982	0.013	CbGeAlD
Caffeine—RYR1—female reproductive system—urinary bladder cancer	0.000972	0.0129	CbGeAlD
Caffeine—PIK3CA—female reproductive system—urinary bladder cancer	0.000972	0.0129	CbGeAlD
Caffeine—ADORA2B—smooth muscle tissue—urinary bladder cancer	0.000927	0.0123	CbGeAlD
Caffeine—Hyperglycaemia—Valrubicin—urinary bladder cancer	0.000923	0.0217	CcSEcCtD
Caffeine—PIK3CB—vagina—urinary bladder cancer	0.000888	0.0118	CbGeAlD
Caffeine—RYR1—vagina—urinary bladder cancer	0.000879	0.0117	CbGeAlD
Caffeine—PIK3CA—vagina—urinary bladder cancer	0.000879	0.0117	CbGeAlD
Caffeine—ADORA2B—urethra—urinary bladder cancer	0.000877	0.0116	CbGeAlD
Caffeine—CYP3A4—urine—urinary bladder cancer	0.000862	0.0114	CbGeAlD
Caffeine—CYP2D6—urine—urinary bladder cancer	0.000848	0.0113	CbGeAlD
Caffeine—ATM—lymph node—urinary bladder cancer	0.000742	0.00986	CbGeAlD
Caffeine—PRKDC—lymph node—urinary bladder cancer	0.000702	0.00932	CbGeAlD
Caffeine—PDE4B—prostate gland—urinary bladder cancer	0.000696	0.00924	CbGeAlD
Caffeine—PIK3CD—lymph node—urinary bladder cancer	0.000658	0.00874	CbGeAlD
Caffeine—ADORA2B—vagina—urinary bladder cancer	0.000647	0.00858	CbGeAlD
Caffeine—ADORA1—renal system—urinary bladder cancer	0.000641	0.00851	CbGeAlD
Caffeine—ADORA1—urethra—urinary bladder cancer	0.00063	0.00836	CbGeAlD
Caffeine—Renal failure—Mitomycin—urinary bladder cancer	0.000618	0.0145	CcSEcCtD
Caffeine—CYP1B1—prostate gland—urinary bladder cancer	0.000596	0.00792	CbGeAlD
Caffeine—ADORA2A—female reproductive system—urinary bladder cancer	0.000595	0.0079	CbGeAlD
Caffeine—PIK3CB—lymph node—urinary bladder cancer	0.000574	0.00763	CbGeAlD
Caffeine—PIK3CA—lymph node—urinary bladder cancer	0.000568	0.00755	CbGeAlD
Caffeine—Impaired healing—Methotrexate—urinary bladder cancer	0.000562	0.0132	CcSEcCtD
Caffeine—Infection—Carboplatin—urinary bladder cancer	0.000535	0.0126	CcSEcCtD
Caffeine—ADORA1—female reproductive system—urinary bladder cancer	0.000514	0.00682	CbGeAlD
Caffeine—Pulmonary oedema—Thiotepa—urinary bladder cancer	0.000503	0.0118	CcSEcCtD
Caffeine—Creatinine increased—Gemcitabine—urinary bladder cancer	0.000499	0.0117	CcSEcCtD
Caffeine—Sepsis—Thiotepa—urinary bladder cancer	0.00049	0.0115	CcSEcCtD
Caffeine—PDE4B—urethra—urinary bladder cancer	0.000466	0.00619	CbGeAlD
Caffeine—ADORA1—vagina—urinary bladder cancer	0.000464	0.00617	CbGeAlD
Caffeine—Deafness—Thiotepa—urinary bladder cancer	0.000458	0.0108	CcSEcCtD
Caffeine—Hypertension—Mitomycin—urinary bladder cancer	0.000424	0.00995	CcSEcCtD
Caffeine—Pulmonary oedema—Gemcitabine—urinary bladder cancer	0.000423	0.00993	CcSEcCtD
Caffeine—CYP1B1—smooth muscle tissue—urinary bladder cancer	0.000422	0.00561	CbGeAlD
Caffeine—Sepsis—Gemcitabine—urinary bladder cancer	0.000412	0.00968	CcSEcCtD
Caffeine—CYP3A5—prostate gland—urinary bladder cancer	0.000412	0.00547	CbGeAlD
Caffeine—CYP1B1—renal system—urinary bladder cancer	0.000407	0.0054	CbGeAlD
Caffeine—Sepsis—Fluorouracil—urinary bladder cancer	0.000405	0.00952	CcSEcCtD
Caffeine—Deafness—Gemcitabine—urinary bladder cancer	0.000386	0.00905	CcSEcCtD
Caffeine—CYP2E1—prostate gland—urinary bladder cancer	0.000385	0.00511	CbGeAlD
Caffeine—Blood creatinine increased—Thiotepa—urinary bladder cancer	0.000384	0.00902	CcSEcCtD
Caffeine—PDE4B—female reproductive system—urinary bladder cancer	0.00038	0.00504	CbGeAlD
Caffeine—Rash—Valrubicin—urinary bladder cancer	0.000367	0.00861	CcSEcCtD
Caffeine—Dermatitis—Valrubicin—urinary bladder cancer	0.000366	0.0086	CcSEcCtD
Caffeine—Deafness—Cisplatin—urinary bladder cancer	0.000359	0.00844	CcSEcCtD
Caffeine—Dyspnoea—Mitomycin—urinary bladder cancer	0.000357	0.00839	CcSEcCtD
Caffeine—Sepsis—Etoposide—urinary bladder cancer	0.000352	0.00827	CcSEcCtD
Caffeine—PDE4B—vagina—urinary bladder cancer	0.000344	0.00456	CbGeAlD
Caffeine—Gastrointestinal haemorrhage—Fluorouracil—urinary bladder cancer	0.000339	0.00796	CcSEcCtD
Caffeine—Hypercalcaemia—Epirubicin—urinary bladder cancer	0.000327	0.00769	CcSEcCtD
Caffeine—CYP1B1—female reproductive system—urinary bladder cancer	0.000326	0.00432	CbGeAlD
Caffeine—CYP2E1—seminal vesicle—urinary bladder cancer	0.000325	0.00432	CbGeAlD
Caffeine—Irritability—Fluorouracil—urinary bladder cancer	0.000324	0.0076	CcSEcCtD
Caffeine—Blood creatinine increased—Gemcitabine—urinary bladder cancer	0.000323	0.00759	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Cisplatin—urinary bladder cancer	0.000321	0.00755	CcSEcCtD
Caffeine—Hyperglycaemia—Thiotepa—urinary bladder cancer	0.00032	0.00751	CcSEcCtD
Caffeine—Infestation NOS—Thiotepa—urinary bladder cancer	0.000316	0.00742	CcSEcCtD
Caffeine—Infestation—Thiotepa—urinary bladder cancer	0.000316	0.00742	CcSEcCtD
Caffeine—CYP2C8—renal system—urinary bladder cancer	0.000311	0.00413	CbGeAlD
Caffeine—Dry skin—Fluorouracil—urinary bladder cancer	0.000311	0.0073	CcSEcCtD
Caffeine—Renal failure—Thiotepa—urinary bladder cancer	0.000311	0.00729	CcSEcCtD
Caffeine—CYP1A1—epithelium—urinary bladder cancer	0.00031	0.00411	CbGeAlD
Caffeine—Irritability—Cisplatin—urinary bladder cancer	0.000307	0.00721	CcSEcCtD
Caffeine—Hypercalcaemia—Doxorubicin—urinary bladder cancer	0.000303	0.00711	CcSEcCtD
Caffeine—Blood creatinine increased—Cisplatin—urinary bladder cancer	0.000301	0.00707	CcSEcCtD
Caffeine—ADORA1—lymph node—urinary bladder cancer	0.0003	0.00399	CbGeAlD
Caffeine—CYP1A2—renal system—urinary bladder cancer	0.000291	0.00387	CbGeAlD
Caffeine—CYP1A1—renal system—urinary bladder cancer	0.000287	0.00382	CbGeAlD
Caffeine—Haemoglobin—Thiotepa—urinary bladder cancer	0.000285	0.00669	CcSEcCtD
Caffeine—Haemorrhage—Thiotepa—urinary bladder cancer	0.000284	0.00666	CcSEcCtD
Caffeine—CYP1A1—urethra—urinary bladder cancer	0.000282	0.00375	CbGeAlD
Caffeine—CYP3A5—renal system—urinary bladder cancer	0.000281	0.00373	CbGeAlD
Caffeine—Hyperglycaemia—Gemcitabine—urinary bladder cancer	0.000269	0.00631	CcSEcCtD
Caffeine—Cardiac disorder—Thiotepa—urinary bladder cancer	0.000263	0.00618	CcSEcCtD
Caffeine—CYP2E1—renal system—urinary bladder cancer	0.000262	0.00348	CbGeAlD
Caffeine—Infestation—Fluorouracil—urinary bladder cancer	0.000261	0.00614	CcSEcCtD
Caffeine—Infestation NOS—Fluorouracil—urinary bladder cancer	0.000261	0.00614	CcSEcCtD
Caffeine—Renal failure—Gemcitabine—urinary bladder cancer	0.000261	0.00614	CcSEcCtD
Caffeine—CYP2E1—urethra—urinary bladder cancer	0.000257	0.00342	CbGeAlD
Caffeine—Immune system disorder—Thiotepa—urinary bladder cancer	0.000256	0.00602	CcSEcCtD
Caffeine—Rash—Mitomycin—urinary bladder cancer	0.000253	0.00593	CcSEcCtD
Caffeine—Dermatitis—Mitomycin—urinary bladder cancer	0.000252	0.00593	CcSEcCtD
Caffeine—CYP2C8—female reproductive system—urinary bladder cancer	0.000249	0.00331	CbGeAlD
Caffeine—Malnutrition—Thiotepa—urinary bladder cancer	0.000247	0.0058	CcSEcCtD
Caffeine—Renal failure—Cisplatin—urinary bladder cancer	0.000244	0.00572	CcSEcCtD
Caffeine—Nervousness—Thiotepa—urinary bladder cancer	0.00024	0.00563	CcSEcCtD
Caffeine—Haemoglobin—Gemcitabine—urinary bladder cancer	0.00024	0.00563	CcSEcCtD
Caffeine—Creatinine increased—Epirubicin—urinary bladder cancer	0.000239	0.00561	CcSEcCtD
Caffeine—Haemorrhage—Gemcitabine—urinary bladder cancer	0.000239	0.0056	CcSEcCtD
Caffeine—Haemoglobin—Fluorouracil—urinary bladder cancer	0.000236	0.00554	CcSEcCtD
Caffeine—Haemorrhage—Fluorouracil—urinary bladder cancer	0.000235	0.00551	CcSEcCtD
Caffeine—CYP1A1—female reproductive system—urinary bladder cancer	0.00023	0.00306	CbGeAlD
Caffeine—Infestation—Etoposide—urinary bladder cancer	0.000227	0.00533	CcSEcCtD
Caffeine—Infestation NOS—Etoposide—urinary bladder cancer	0.000227	0.00533	CcSEcCtD
Caffeine—Agitation—Thiotepa—urinary bladder cancer	0.000227	0.00533	CcSEcCtD
Caffeine—CYP2C8—vagina—urinary bladder cancer	0.000226	0.00299	CbGeAlD
Caffeine—Renal failure—Etoposide—urinary bladder cancer	0.000223	0.00524	CcSEcCtD
Caffeine—PDE4B—lymph node—urinary bladder cancer	0.000222	0.00295	CbGeAlD
Caffeine—CYP2C9—female reproductive system—urinary bladder cancer	0.000221	0.00294	CbGeAlD
Caffeine—Cardiac disorder—Gemcitabine—urinary bladder cancer	0.000221	0.0052	CcSEcCtD
Caffeine—Creatinine increased—Doxorubicin—urinary bladder cancer	0.000221	0.00519	CcSEcCtD
Caffeine—Urine output increased—Methotrexate—urinary bladder cancer	0.00022	0.00516	CcSEcCtD
Caffeine—ABCB1—prostate gland—urinary bladder cancer	0.000219	0.00291	CbGeAlD
Caffeine—Pulmonary oedema—Methotrexate—urinary bladder cancer	0.000216	0.00508	CcSEcCtD
Caffeine—Immune system disorder—Gemcitabine—urinary bladder cancer	0.000216	0.00506	CcSEcCtD
Caffeine—Convulsion—Thiotepa—urinary bladder cancer	0.000214	0.00502	CcSEcCtD
Caffeine—Hypertension—Thiotepa—urinary bladder cancer	0.000213	0.00501	CcSEcCtD
Caffeine—Sepsis—Methotrexate—urinary bladder cancer	0.000211	0.00495	CcSEcCtD
Caffeine—CYP3A4—renal system—urinary bladder cancer	0.000211	0.0028	CbGeAlD
Caffeine—CYP2E1—female reproductive system—urinary bladder cancer	0.00021	0.00279	CbGeAlD
Caffeine—CYP1A1—vagina—urinary bladder cancer	0.000208	0.00276	CbGeAlD
Caffeine—CYP2D6—renal system—urinary bladder cancer	0.000208	0.00276	CbGeAlD
Caffeine—Cardiac disorder—Cisplatin—urinary bladder cancer	0.000206	0.00485	CcSEcCtD
Caffeine—CYP3A5—vagina—urinary bladder cancer	0.000204	0.0027	CbGeAlD
Caffeine—Pulmonary oedema—Epirubicin—urinary bladder cancer	0.000202	0.00475	CcSEcCtD
Caffeine—Immune system disorder—Cisplatin—urinary bladder cancer	0.000201	0.00472	CcSEcCtD
Caffeine—Infection—Thiotepa—urinary bladder cancer	0.0002	0.0047	CcSEcCtD
Caffeine—Nervous system disorder—Thiotepa—urinary bladder cancer	0.000198	0.00464	CcSEcCtD
Caffeine—Sepsis—Epirubicin—urinary bladder cancer	0.000197	0.00463	CcSEcCtD
Caffeine—Tachycardia—Thiotepa—urinary bladder cancer	0.000197	0.00462	CcSEcCtD
Caffeine—Skin disorder—Thiotepa—urinary bladder cancer	0.000196	0.0046	CcSEcCtD
Caffeine—Malnutrition—Cisplatin—urinary bladder cancer	0.000194	0.00455	CcSEcCtD
Caffeine—CYP1B1—lymph node—urinary bladder cancer	0.00019	0.00253	CbGeAlD
Caffeine—Cardiac disorder—Etoposide—urinary bladder cancer	0.000189	0.00444	CcSEcCtD
Caffeine—Pulmonary oedema—Doxorubicin—urinary bladder cancer	0.000187	0.0044	CcSEcCtD
Caffeine—ABCB1—seminal vesicle—urinary bladder cancer	0.000185	0.00246	CbGeAlD
Caffeine—Immune system disorder—Etoposide—urinary bladder cancer	0.000184	0.00432	CcSEcCtD
Caffeine—Sepsis—Doxorubicin—urinary bladder cancer	0.000183	0.00429	CcSEcCtD
Caffeine—Hypertension—Gemcitabine—urinary bladder cancer	0.000179	0.00421	CcSEcCtD
Caffeine—Convulsion—Fluorouracil—urinary bladder cancer	0.000177	0.00416	CcSEcCtD
Caffeine—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.000174	0.00409	CcSEcCtD
Caffeine—Hypoglycaemia—Epirubicin—urinary bladder cancer	0.000169	0.00397	CcSEcCtD
Caffeine—CYP3A4—female reproductive system—urinary bladder cancer	0.000169	0.00224	CbGeAlD
Caffeine—Infection—Gemcitabine—urinary bladder cancer	0.000168	0.00395	CcSEcCtD
Caffeine—Irritability—Methotrexate—urinary bladder cancer	0.000168	0.00395	CcSEcCtD
Caffeine—Convulsion—Cisplatin—urinary bladder cancer	0.000168	0.00394	CcSEcCtD
Caffeine—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.000166	0.0039	CcSEcCtD
Caffeine—CYP2D6—female reproductive system—urinary bladder cancer	0.000166	0.00221	CbGeAlD
Caffeine—Infection—Fluorouracil—urinary bladder cancer	0.000166	0.00389	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Epirubicin—urinary bladder cancer	0.000165	0.00388	CcSEcCtD
Caffeine—Skin disorder—Gemcitabine—urinary bladder cancer	0.000165	0.00387	CcSEcCtD
Caffeine—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.000163	0.00384	CcSEcCtD
Caffeine—Tachycardia—Fluorouracil—urinary bladder cancer	0.000163	0.00382	CcSEcCtD
Caffeine—ABCB1—epithelium—urinary bladder cancer	0.000161	0.00214	CbGeAlD
Caffeine—Infection—Cisplatin—urinary bladder cancer	0.000157	0.00369	CcSEcCtD
Caffeine—Hypoglycaemia—Doxorubicin—urinary bladder cancer	0.000157	0.00368	CcSEcCtD
Caffeine—Nervous system disorder—Cisplatin—urinary bladder cancer	0.000155	0.00364	CcSEcCtD
Caffeine—Blood creatinine increased—Epirubicin—urinary bladder cancer	0.000155	0.00363	CcSEcCtD
Caffeine—Tachycardia—Cisplatin—urinary bladder cancer	0.000154	0.00362	CcSEcCtD
Caffeine—Convulsion—Etoposide—urinary bladder cancer	0.000154	0.00361	CcSEcCtD
Caffeine—Skin disorder—Cisplatin—urinary bladder cancer	0.000153	0.0036	CcSEcCtD
Caffeine—Hypertension—Etoposide—urinary bladder cancer	0.000153	0.0036	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Doxorubicin—urinary bladder cancer	0.000153	0.00359	CcSEcCtD
Caffeine—Dry skin—Epirubicin—urinary bladder cancer	0.000151	0.00355	CcSEcCtD
Caffeine—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000151	0.00355	CcSEcCtD
Caffeine—ABCB1—renal system—urinary bladder cancer	0.000149	0.00198	CbGeAlD
Caffeine—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000149	0.00349	CcSEcCtD
Caffeine—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000148	0.00349	CcSEcCtD
Caffeine—ABCB1—urethra—urinary bladder cancer	0.000147	0.00195	CbGeAlD
Caffeine—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000146	0.00344	CcSEcCtD
Caffeine—Gastritis—Epirubicin—urinary bladder cancer	0.000146	0.00343	CcSEcCtD
Caffeine—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000144	0.00338	CcSEcCtD
Caffeine—Infection—Etoposide—urinary bladder cancer	0.000144	0.00338	CcSEcCtD
Caffeine—Blood creatinine increased—Doxorubicin—urinary bladder cancer	0.000143	0.00336	CcSEcCtD
Caffeine—Tachycardia—Etoposide—urinary bladder cancer	0.000141	0.00332	CcSEcCtD
Caffeine—Dyspnoea—Cisplatin—urinary bladder cancer	0.000141	0.00331	CcSEcCtD
Caffeine—Skin disorder—Etoposide—urinary bladder cancer	0.000141	0.0033	CcSEcCtD
Caffeine—Dry skin—Doxorubicin—urinary bladder cancer	0.00014	0.00329	CcSEcCtD
Caffeine—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000136	0.0032	CcSEcCtD
Caffeine—Infestation NOS—Methotrexate—urinary bladder cancer	0.000136	0.00319	CcSEcCtD
Caffeine—Infestation—Methotrexate—urinary bladder cancer	0.000136	0.00319	CcSEcCtD
Caffeine—Gastritis—Doxorubicin—urinary bladder cancer	0.000135	0.00317	CcSEcCtD
Caffeine—CYP1A1—lymph node—urinary bladder cancer	0.000135	0.00179	CbGeAlD
Caffeine—Renal failure—Methotrexate—urinary bladder cancer	0.000134	0.00314	CcSEcCtD
Caffeine—Dyspnoea—Etoposide—urinary bladder cancer	0.000129	0.00303	CcSEcCtD
Caffeine—Hyperglycaemia—Epirubicin—urinary bladder cancer	0.000129	0.00302	CcSEcCtD
Caffeine—Infestation NOS—Epirubicin—urinary bladder cancer	0.000127	0.00299	CcSEcCtD
Caffeine—Infestation—Epirubicin—urinary bladder cancer	0.000127	0.00299	CcSEcCtD
Caffeine—Rash—Thiotepa—urinary bladder cancer	0.000127	0.00298	CcSEcCtD
Caffeine—Dermatitis—Thiotepa—urinary bladder cancer	0.000127	0.00298	CcSEcCtD
Caffeine—Renal failure—Epirubicin—urinary bladder cancer	0.000125	0.00294	CcSEcCtD
Caffeine—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000125	0.00293	CcSEcCtD
Caffeine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000123	0.00288	CcSEcCtD
Caffeine—Haemoglobin—Methotrexate—urinary bladder cancer	0.000123	0.00288	CcSEcCtD
Caffeine—Haemorrhage—Methotrexate—urinary bladder cancer	0.000122	0.00287	CcSEcCtD
Caffeine—ABCB1—female reproductive system—urinary bladder cancer	0.00012	0.00159	CbGeAlD
Caffeine—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.000119	0.0028	CcSEcCtD
Caffeine—Infestation NOS—Doxorubicin—urinary bladder cancer	0.000118	0.00276	CcSEcCtD
Caffeine—Infestation—Doxorubicin—urinary bladder cancer	0.000118	0.00276	CcSEcCtD
Caffeine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000116	0.00273	CcSEcCtD
Caffeine—Renal failure—Doxorubicin—urinary bladder cancer	0.000116	0.00272	CcSEcCtD
Caffeine—Haemoglobin—Epirubicin—urinary bladder cancer	0.000115	0.0027	CcSEcCtD
Caffeine—Haemorrhage—Epirubicin—urinary bladder cancer	0.000114	0.00268	CcSEcCtD
Caffeine—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000113	0.00266	CcSEcCtD
Caffeine—Immune system disorder—Methotrexate—urinary bladder cancer	0.00011	0.00259	CcSEcCtD
Caffeine—ABCB1—vagina—urinary bladder cancer	0.000108	0.00144	CbGeAlD
Caffeine—Rash—Gemcitabine—urinary bladder cancer	0.000107	0.00251	CcSEcCtD
Caffeine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000107	0.00251	CcSEcCtD
Caffeine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000107	0.0025	CcSEcCtD
Caffeine—Malnutrition—Methotrexate—urinary bladder cancer	0.000106	0.00249	CcSEcCtD
Caffeine—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000106	0.00249	CcSEcCtD
Caffeine—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000106	0.00249	CcSEcCtD
Caffeine—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000106	0.00248	CcSEcCtD
Caffeine—Rash—Fluorouracil—urinary bladder cancer	0.000105	0.00247	CcSEcCtD
Caffeine—Dermatitis—Fluorouracil—urinary bladder cancer	0.000105	0.00247	CcSEcCtD
Caffeine—Immune system disorder—Epirubicin—urinary bladder cancer	0.000103	0.00242	CcSEcCtD
Caffeine—Rash—Cisplatin—urinary bladder cancer	9.96e-05	0.00234	CcSEcCtD
Caffeine—Dermatitis—Cisplatin—urinary bladder cancer	9.95e-05	0.00234	CcSEcCtD
Caffeine—Malnutrition—Epirubicin—urinary bladder cancer	9.94e-05	0.00233	CcSEcCtD
Caffeine—Cardiac disorder—Doxorubicin—urinary bladder cancer	9.81e-05	0.0023	CcSEcCtD
Caffeine—Nervousness—Epirubicin—urinary bladder cancer	9.66e-05	0.00227	CcSEcCtD
Caffeine—Immune system disorder—Doxorubicin—urinary bladder cancer	9.54e-05	0.00224	CcSEcCtD
Caffeine—Convulsion—Methotrexate—urinary bladder cancer	9.2e-05	0.00216	CcSEcCtD
Caffeine—Malnutrition—Doxorubicin—urinary bladder cancer	9.2e-05	0.00216	CcSEcCtD
Caffeine—Agitation—Epirubicin—urinary bladder cancer	9.14e-05	0.00215	CcSEcCtD
Caffeine—Rash—Etoposide—urinary bladder cancer	9.13e-05	0.00214	CcSEcCtD
Caffeine—Dermatitis—Etoposide—urinary bladder cancer	9.12e-05	0.00214	CcSEcCtD
Caffeine—Nervousness—Doxorubicin—urinary bladder cancer	8.93e-05	0.0021	CcSEcCtD
Caffeine—Convulsion—Epirubicin—urinary bladder cancer	8.61e-05	0.00202	CcSEcCtD
Caffeine—Infection—Methotrexate—urinary bladder cancer	8.61e-05	0.00202	CcSEcCtD
Caffeine—Hypertension—Epirubicin—urinary bladder cancer	8.58e-05	0.00202	CcSEcCtD
Caffeine—Nervous system disorder—Methotrexate—urinary bladder cancer	8.5e-05	0.002	CcSEcCtD
Caffeine—Agitation—Doxorubicin—urinary bladder cancer	8.45e-05	0.00199	CcSEcCtD
Caffeine—Skin disorder—Methotrexate—urinary bladder cancer	8.42e-05	0.00198	CcSEcCtD
Caffeine—Infection—Epirubicin—urinary bladder cancer	8.06e-05	0.00189	CcSEcCtD
Caffeine—Convulsion—Doxorubicin—urinary bladder cancer	7.97e-05	0.00187	CcSEcCtD
Caffeine—Nervous system disorder—Epirubicin—urinary bladder cancer	7.96e-05	0.00187	CcSEcCtD
Caffeine—Hypertension—Doxorubicin—urinary bladder cancer	7.94e-05	0.00187	CcSEcCtD
Caffeine—Tachycardia—Epirubicin—urinary bladder cancer	7.92e-05	0.00186	CcSEcCtD
Caffeine—Skin disorder—Epirubicin—urinary bladder cancer	7.88e-05	0.00185	CcSEcCtD
Caffeine—Dyspnoea—Methotrexate—urinary bladder cancer	7.73e-05	0.00182	CcSEcCtD
Caffeine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	7.49e-05	0.00176	CcSEcCtD
Caffeine—Infection—Doxorubicin—urinary bladder cancer	7.46e-05	0.00175	CcSEcCtD
Caffeine—Nervous system disorder—Doxorubicin—urinary bladder cancer	7.36e-05	0.00173	CcSEcCtD
Caffeine—Tachycardia—Doxorubicin—urinary bladder cancer	7.33e-05	0.00172	CcSEcCtD
Caffeine—Skin disorder—Doxorubicin—urinary bladder cancer	7.29e-05	0.00171	CcSEcCtD
Caffeine—Dyspnoea—Epirubicin—urinary bladder cancer	7.23e-05	0.0017	CcSEcCtD
Caffeine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	7.01e-05	0.00165	CcSEcCtD
Caffeine—ABCB1—lymph node—urinary bladder cancer	6.99e-05	0.000929	CbGeAlD
Caffeine—Dyspnoea—Doxorubicin—urinary bladder cancer	6.69e-05	0.00157	CcSEcCtD
Caffeine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	6.48e-05	0.00152	CcSEcCtD
Caffeine—Hypersensitivity—Methotrexate—urinary bladder cancer	6.39e-05	0.0015	CcSEcCtD
Caffeine—Hypersensitivity—Epirubicin—urinary bladder cancer	5.98e-05	0.0014	CcSEcCtD
Caffeine—Hypersensitivity—Doxorubicin—urinary bladder cancer	5.53e-05	0.0013	CcSEcCtD
Caffeine—Rash—Methotrexate—urinary bladder cancer	5.47e-05	0.00128	CcSEcCtD
Caffeine—Dermatitis—Methotrexate—urinary bladder cancer	5.46e-05	0.00128	CcSEcCtD
Caffeine—Rash—Epirubicin—urinary bladder cancer	5.12e-05	0.0012	CcSEcCtD
Caffeine—Dermatitis—Epirubicin—urinary bladder cancer	5.11e-05	0.0012	CcSEcCtD
Caffeine—Rash—Doxorubicin—urinary bladder cancer	4.73e-05	0.00111	CcSEcCtD
Caffeine—Dermatitis—Doxorubicin—urinary bladder cancer	4.73e-05	0.00111	CcSEcCtD
Caffeine—PIK3CA—Disease—MYC—urinary bladder cancer	3.78e-06	2.61e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—EGFR—urinary bladder cancer	3.77e-06	2.6e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—HRAS—urinary bladder cancer	3.77e-06	2.6e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—HRAS—urinary bladder cancer	3.77e-06	2.6e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—SRC—urinary bladder cancer	3.75e-06	2.59e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—CXCL8—urinary bladder cancer	3.75e-06	2.58e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—ERBB2—urinary bladder cancer	3.74e-06	2.58e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—HRAS—urinary bladder cancer	3.72e-06	2.56e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—SRC—urinary bladder cancer	3.72e-06	2.56e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—EGFR—urinary bladder cancer	3.7e-06	2.55e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CREBBP—urinary bladder cancer	3.69e-06	2.54e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—RRM2—urinary bladder cancer	3.67e-06	2.53e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—IGF1—urinary bladder cancer	3.64e-06	2.51e-05	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—EP300—urinary bladder cancer	3.64e-06	2.51e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—NQO1—urinary bladder cancer	3.64e-06	2.51e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—RRM2—urinary bladder cancer	3.64e-06	2.5e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—IL2—urinary bladder cancer	3.62e-06	2.5e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—EGFR—urinary bladder cancer	3.62e-06	2.5e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	3.61e-06	2.49e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—HPGDS—urinary bladder cancer	3.6e-06	2.48e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—ENO2—urinary bladder cancer	3.6e-06	2.48e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—NAT2—urinary bladder cancer	3.6e-06	2.48e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—IL2—urinary bladder cancer	3.58e-06	2.47e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—KRAS—urinary bladder cancer	3.57e-06	2.46e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CXCL8—urinary bladder cancer	3.55e-06	2.44e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—CCND1—urinary bladder cancer	3.53e-06	2.43e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.53e-06	2.43e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—HRAS—urinary bladder cancer	3.52e-06	2.43e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—KRAS—urinary bladder cancer	3.5e-06	2.41e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—GSTT1—urinary bladder cancer	3.5e-06	2.41e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—CCND1—urinary bladder cancer	3.49e-06	2.4e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—MMP9—urinary bladder cancer	3.43e-06	2.36e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—KRAS—urinary bladder cancer	3.42e-06	2.36e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—CDKN1A—urinary bladder cancer	3.42e-06	2.35e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—PTEN—urinary bladder cancer	3.41e-06	2.35e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—ENO2—urinary bladder cancer	3.4e-06	2.34e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	3.4e-06	2.34e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—IL2—urinary bladder cancer	3.39e-06	2.34e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—MMP9—urinary bladder cancer	3.39e-06	2.33e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—CDKN1A—urinary bladder cancer	3.38e-06	2.33e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—PTEN—urinary bladder cancer	3.37e-06	2.32e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ENO2—urinary bladder cancer	3.37e-06	2.32e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	3.37e-06	2.32e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—MYC—urinary bladder cancer	3.36e-06	2.32e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.35e-06	2.31e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—RHOA—urinary bladder cancer	3.34e-06	2.3e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—NQO1—urinary bladder cancer	3.33e-06	2.3e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—MYC—urinary bladder cancer	3.33e-06	2.3e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CCND1—urinary bladder cancer	3.3e-06	2.28e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	3.29e-06	2.27e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—EGFR—urinary bladder cancer	3.29e-06	2.27e-05	CbGpPWpGaD
Caffeine—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.27e-06	2.25e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	3.27e-06	2.25e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—EGFR—urinary bladder cancer	3.26e-06	2.25e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—EP300—urinary bladder cancer	3.25e-06	2.24e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PPARG—urinary bladder cancer	3.24e-06	2.23e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.24e-06	2.23e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—HRAS—urinary bladder cancer	3.22e-06	2.22e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—GSTP1—urinary bladder cancer	3.22e-06	2.22e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.22e-06	2.22e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—EP300—urinary bladder cancer	3.21e-06	2.21e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	3.21e-06	2.21e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—MMP9—urinary bladder cancer	3.21e-06	2.21e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CDKN1A—urinary bladder cancer	3.2e-06	2.2e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—PTEN—urinary bladder cancer	3.19e-06	2.2e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—TP53—urinary bladder cancer	3.17e-06	2.18e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—SRC—urinary bladder cancer	3.16e-06	2.18e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—SRC—urinary bladder cancer	3.12e-06	2.15e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—CREBBP—urinary bladder cancer	3.12e-06	2.15e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—KRAS—urinary bladder cancer	3.11e-06	2.14e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—RRM2—urinary bladder cancer	3.11e-06	2.14e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—ERBB2—urinary bladder cancer	3.09e-06	2.13e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—KRAS—urinary bladder cancer	3.08e-06	2.12e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.08e-06	2.12e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	3.07e-06	2.12e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—EP300—urinary bladder cancer	3.04e-06	2.1e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—GSTP1—urinary bladder cancer	3.03e-06	2.09e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—HRAS—urinary bladder cancer	3.03e-06	2.09e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—TYMS—urinary bladder cancer	2.99e-06	2.06e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—TYMS—urinary bladder cancer	2.98e-06	2.06e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—HRAS—urinary bladder cancer	2.97e-06	2.05e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—SRC—urinary bladder cancer	2.96e-06	2.04e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	2.96e-06	2.04e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	2.96e-06	2.04e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	2.95e-06	2.03e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	2.95e-06	2.03e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.93e-06	2.02e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CXCL8—urinary bladder cancer	2.93e-06	2.02e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PPARG—urinary bladder cancer	2.93e-06	2.02e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—HRAS—urinary bladder cancer	2.91e-06	2e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—NQO1—urinary bladder cancer	2.9e-06	2e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	2.88e-06	1.98e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ENO2—urinary bladder cancer	2.88e-06	1.98e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.86e-06	1.97e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—MYC—urinary bladder cancer	2.83e-06	1.95e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—GPX1—urinary bladder cancer	2.83e-06	1.95e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—GPX1—urinary bladder cancer	2.83e-06	1.95e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.82e-06	1.94e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—TYMS—urinary bladder cancer	2.82e-06	1.94e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	2.81e-06	1.94e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—MYC—urinary bladder cancer	2.8e-06	1.93e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—IL2—urinary bladder cancer	2.8e-06	1.93e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	2.79e-06	1.92e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—NCOR1—urinary bladder cancer	2.79e-06	1.92e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—GSTM1—urinary bladder cancer	2.79e-06	1.92e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	2.78e-06	1.92e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	2.78e-06	1.92e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	2.78e-06	1.91e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	2.77e-06	1.91e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—EGFR—urinary bladder cancer	2.77e-06	1.91e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—TP53—urinary bladder cancer	2.76e-06	1.9e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.75e-06	1.89e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—EGFR—urinary bladder cancer	2.74e-06	1.89e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—NQO1—urinary bladder cancer	2.74e-06	1.89e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—TP53—urinary bladder cancer	2.74e-06	1.89e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CCND1—urinary bladder cancer	2.73e-06	1.88e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—NQO1—urinary bladder cancer	2.71e-06	1.87e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.69e-06	1.85e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—GPX1—urinary bladder cancer	2.67e-06	1.84e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—MYC—urinary bladder cancer	2.65e-06	1.83e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—MMP9—urinary bladder cancer	2.65e-06	1.82e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—HRAS—urinary bladder cancer	2.64e-06	1.82e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CDKN1A—urinary bladder cancer	2.64e-06	1.82e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.63e-06	1.81e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—PTEN—urinary bladder cancer	2.63e-06	1.81e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—ERCC2—urinary bladder cancer	2.62e-06	1.81e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—KRAS—urinary bladder cancer	2.62e-06	1.8e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—HRAS—urinary bladder cancer	2.62e-06	1.8e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	2.61e-06	1.8e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	2.61e-06	1.8e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—EGFR—urinary bladder cancer	2.59e-06	1.79e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—KRAS—urinary bladder cancer	2.59e-06	1.78e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—TYMS—urinary bladder cancer	2.59e-06	1.78e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	2.56e-06	1.76e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	2.56e-06	1.76e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PTGS2—urinary bladder cancer	2.55e-06	1.76e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—EP300—urinary bladder cancer	2.51e-06	1.73e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—MTHFR—urinary bladder cancer	2.46e-06	1.7e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—KRAS—urinary bladder cancer	2.45e-06	1.69e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—GPX1—urinary bladder cancer	2.45e-06	1.69e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—SRC—urinary bladder cancer	2.44e-06	1.68e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—GSTP1—urinary bladder cancer	2.42e-06	1.67e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	2.4e-06	1.66e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	2.4e-06	1.65e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—TP53—urinary bladder cancer	2.33e-06	1.6e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—NQO1—urinary bladder cancer	2.32e-06	1.6e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	2.3e-06	1.59e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—TP53—urinary bladder cancer	2.3e-06	1.58e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.3e-06	1.58e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	2.28e-06	1.57e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	2.26e-06	1.56e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	2.26e-06	1.56e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—TYMS—urinary bladder cancer	2.25e-06	1.55e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.25e-06	1.55e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—GSTM1—urinary bladder cancer	2.23e-06	1.53e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—NCOR1—urinary bladder cancer	2.23e-06	1.53e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—HRAS—urinary bladder cancer	2.23e-06	1.53e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PTEN—urinary bladder cancer	2.23e-06	1.53e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	2.22e-06	1.53e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	2.22e-06	1.53e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—HRAS—urinary bladder cancer	2.2e-06	1.52e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.19e-06	1.51e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—MYC—urinary bladder cancer	2.19e-06	1.51e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—TP53—urinary bladder cancer	2.18e-06	1.5e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	2.15e-06	1.48e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—EGFR—urinary bladder cancer	2.14e-06	1.47e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—GPX1—urinary bladder cancer	2.13e-06	1.47e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—TYMS—urinary bladder cancer	2.12e-06	1.46e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—EP300—urinary bladder cancer	2.12e-06	1.46e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PPARG—urinary bladder cancer	2.12e-06	1.46e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PPARG—urinary bladder cancer	2.11e-06	1.46e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—TYMS—urinary bladder cancer	2.1e-06	1.45e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	2.1e-06	1.45e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	2.1e-06	1.45e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—ERCC2—urinary bladder cancer	2.09e-06	1.44e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—HRAS—urinary bladder cancer	2.08e-06	1.43e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	2.08e-06	1.43e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	2.08e-06	1.43e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	2.04e-06	1.4e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	2.03e-06	1.4e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—KRAS—urinary bladder cancer	2.02e-06	1.39e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—GPX1—urinary bladder cancer	2.01e-06	1.38e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PTEN—urinary bladder cancer	2.01e-06	1.38e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PPARG—urinary bladder cancer	2e-06	1.38e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—GPX1—urinary bladder cancer	1.99e-06	1.37e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	1.97e-06	1.36e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—MTHFR—urinary bladder cancer	1.97e-06	1.36e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.96e-06	1.35e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	1.96e-06	1.35e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	1.93e-06	1.33e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—CREBBP—urinary bladder cancer	1.92e-06	1.32e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—EP300—urinary bladder cancer	1.91e-06	1.32e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.87e-06	1.29e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	1.85e-06	1.28e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	1.84e-06	1.27e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PPARG—urinary bladder cancer	1.83e-06	1.26e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—TYMS—urinary bladder cancer	1.8e-06	1.24e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—TP53—urinary bladder cancer	1.8e-06	1.24e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.79e-06	1.23e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	1.78e-06	1.22e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	1.78e-06	1.22e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	1.76e-06	1.21e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—HRAS—urinary bladder cancer	1.72e-06	1.18e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—GPX1—urinary bladder cancer	1.7e-06	1.17e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	1.67e-06	1.15e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	1.67e-06	1.15e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	1.66e-06	1.15e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PPARG—urinary bladder cancer	1.6e-06	1.1e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PTGS2—urinary bladder cancer	1.57e-06	1.08e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	1.57e-06	1.08e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—CREBBP—urinary bladder cancer	1.53e-06	1.06e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	1.5e-06	1.04e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.49e-06	1.03e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PPARG—urinary bladder cancer	1.49e-06	1.03e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PTEN—urinary bladder cancer	1.45e-06	1e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PTEN—urinary bladder cancer	1.45e-06	9.99e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	1.44e-06	9.95e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	1.44e-06	9.93e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	1.43e-06	9.86e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.39e-06	9.56e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—EP300—urinary bladder cancer	1.39e-06	9.55e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—EP300—urinary bladder cancer	1.38e-06	9.53e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.37e-06	9.45e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.37e-06	9.45e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PTEN—urinary bladder cancer	1.37e-06	9.44e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.31e-06	9.05e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—EP300—urinary bladder cancer	1.31e-06	9e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.29e-06	8.88e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PPARG—urinary bladder cancer	1.27e-06	8.78e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PTEN—urinary bladder cancer	1.26e-06	8.66e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PTGS2—urinary bladder cancer	1.26e-06	8.65e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	1.22e-06	8.43e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.21e-06	8.35e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—EP300—urinary bladder cancer	1.2e-06	8.26e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	1.18e-06	8.15e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	1.17e-06	8.08e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PTEN—urinary bladder cancer	1.09e-06	7.54e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—EP300—urinary bladder cancer	1.04e-06	7.19e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	1.03e-06	7.11e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PTEN—urinary bladder cancer	1.02e-06	7.04e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	1e-06	6.9e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—EP300—urinary bladder cancer	9.84e-07	6.78e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	9.83e-07	6.77e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—EP300—urinary bladder cancer	9.75e-07	6.72e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	9.44e-07	6.51e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PTEN—urinary bladder cancer	8.74e-07	6.02e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—EP300—urinary bladder cancer	8.33e-07	5.74e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	7.73e-07	5.33e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	6.74e-07	4.65e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—EP300—urinary bladder cancer	6.43e-07	4.43e-06	CbGpPWpGaD
